IT&E International Group Reports Second Quarter Results (RedNova)
IT&E International Group, Inc. (OTCBB: ITER), a clinical research organization ("CRO") with substantial regulatory support, today reported results for the second quarter ended June 30, 2006. On July 31, 2006, IT&E, which will be renamed Averion International Corp.

Orchid gets FDA okay for Cefotaxime injections (New Kerala)
Chennai, Aug 16: Orchid Chemicals & Pharmaceuticals, a leading player in the Indian drug industry, has received a formal approval from the US Food and Drug Authority (FDA) for three of its abbreviated new drug applications (ANDAs) for Cefotaxime.

Medscape Review Supports Effectiveness And Safety Of New Non-drug Blood Pressure Treatment (Medical News Today)
InterCure, Ltd., today announced the publication of a peer-reviewed clinical overview of seven clinical trials evaluating the efficacy of device-guided breathing. The study's authors conclude that RESPeRATE, an FDA-cleared over-the-counter therapeutic device, is an effective non-pharmacologic treatment option for treating hypertension with no side effects. [click link for full article]